In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

BackgroundSodium-glucose co-transporter 2 inhibitors (SGLT2-i) have shown significant cardiovascular benefits in patients with and without type 2 diabetes mellitus (T2DM). They have also gained interest for their potential anti-arrhythmic role and their ability to reduce the occurrence of atrial fib...

Full description

Bibliographic Details
Main Authors:	Arturo Cesaro, Felice Gragnano, Pasquale Paolisso, Luca Bergamaschi, Emanuele Gallinoro, Celestino Sardu, Niya Mileva, Alberto Foà, Matteo Armillotta, Angelo Sansonetti, Sara Amicone, Andrea Impellizzeri, Giuseppe Esposito, Nuccia Morici, Jacopo Andrea Oreglia, Gianni Casella, Ciro Mauro, Dobrin Vassilev, Nazzareno Galie, Gaetano Santulli, Carmine Pizzi, Emanuele Barbato, Paolo Calabrò, Raffaele Marfella
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	sodium-glucose cotransporter 2 inhibitors (SGLT2-i) acute myocardial infarction atrial fibrillation ventricular arrhythmias ventricular tachycardia hyperglycemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.1012220/full

Similar Items

Reply to SGLT-2 inhibitors: Post-infarction interventional effects
by: Pasquale Paolisso, et al.
Published: (2023-03-01)

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
by: Pasquale Paolisso, et al.
Published: (2022-05-01)

Sex-Related Disparities in Cardiac Masses: Clinical Features and Outcomes
by: Francesco Angeli, et al.
Published: (2023-04-01)

Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores
by: Damiano Fedele, et al.
Published: (2023-08-01)

Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature
by: Lorenzo Bartoli, et al.
Published: (2022-08-01)

GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
by: Raffaele Marfella, et al.
Published: (2024-01-01)

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
by: Lucia Scisciola, et al.
Published: (2023-02-01)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
by: Giuseppe Palmiero, et al.
Published: (2021-05-01)

Editorial: Insights in cardiovascular endocrinology: 2023
by: Gaetano Santulli, et al.
Published: (2023-08-01)

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
by: Annalisa Capuano, et al.
Published: (2022-11-01)

SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis
by: Celestino Sardu, et al.
Published: (2023-04-01)

Editorial: Wnt signaling in endocrine and metabolic disorders
by: Frederic Cailotto, et al.
Published: (2023-08-01)

SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes
by: Raffaele Marfella, et al.
Published: (2023-02-01)

The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension
by: Valentina Trimarco, et al.
Published: (2023-05-01)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
by: Francesco Pelliccia, et al.
Published: (2022-06-01)

Translational Aspects of Cardiovascular Biology: From Bench to Bedside
by: Gaetano Santulli
Published: (2023-04-01)

Dietary Components and Metabolic Dysfunction: Translating Preclinical Studies into Clinical Practice
by: Gaetano Santulli
Published: (2016-10-01)

Editorial: The link between obesity, type 2 diabetes, and mitochondria
by: Moulun Luo, et al.
Published: (2023-06-01)

Editorial: Influence of lifestyle factors in the management of diabetes mellitus
by: Celestino Sardu, et al.
Published: (2023-08-01)

Editorial: Mitochondrial remodeling and dynamic inter-organellar contacts in cardiovascular physiopathology-Volume II
by: Valentina Parra, et al.
Published: (2023-06-01)

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
by: Celestino Sardu, et al.
Published: (2020-05-01)

Choline supplements: An update
by: Urna Kansakar, et al.
Published: (2023-03-01)

Editorial: Frailty and oxidative stress
by: Pasquale Mone, et al.
Published: (2024-03-01)

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease
by: Pasquale Mone, et al.
Published: (2024-02-01)

Endothelial Dysfunction Drives CRTd Outcome at 1-Year Follow-Up: A Novel Role as Biomarker for miR-130a-5p
by: Celestino Sardu, et al.
Published: (2023-01-01)

Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up
by: Celestino Sardu, et al.
Published: (2018-12-01)

Pulmonary hypertension in left heart disease
by: Marco Guazzi, et al.
Published: (2012-12-01)

Editorial: Methods and applications in clinical and translational physiology
by: Gaetano Santulli, et al.
Published: (2023-03-01)

Deferral of Coronary Revascularization in Patients With Reduced Ejection Fraction Based on Physiological Assessment: Impact on Long‐Term Survival
by: Emanuele Gallinoro, et al.
Published: (2022-10-01)

Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells
by: Fahimeh Varzideh, et al.
Published: (2022-04-01)

Aprocitentan: New insights
by: Fahimeh Varzideh, et al.
Published: (2022-12-01)

The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways
by: Luca Bergamaschi, et al.
Published: (2023-06-01)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
by: Teresa Salvatore, et al.
Published: (2022-03-01)

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
by: Imma Forzano, et al.
Published: (2022-12-01)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
by: Felice Gragnano, et al.
Published: (2022-10-01)

Functional role of miR-34a in diabetes and frailty
by: Pasquale Mone, et al.
Published: (2022-07-01)

Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
by: Stanislovas S. Jankauskas, et al.
Published: (2024-03-01)

miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
by: Alessandro Matarese, et al.
Published: (2020-10-01)

Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials
by: Lucia Scisciola, et al.
Published: (2022-09-01)

Editorial: Transcription factors and arrhythmogenesis
by: Yu-Hsun Kao, et al.
Published: (2023-02-01)